EXPE
72
-5
KLAC
57
-4
AFL
62
2
AVY
54
3
HRB
54
5
KMB
34
-6
AVGO
18
-9
EBAY
40
-2
URI
43
-2
GILD
67
4
INTC
40
-3
HP
40
12
AES
47
-3
BLK
64
-2
CL
51
4
JCI
50
-9
KO
65
10
RRC
65
-3
VZ
52
5
VFC
43
4
EXPE
72
-5
KLAC
57
-4
AFL
62
2
AVY
54
3
HRB
54
5
KMB
34
-6
AVGO
18
-9
EBAY
40
-2
URI
43
-2
GILD
67
4
INTC
40
-3
HP
40
12
AES
47
-3
BLK
64
-2
CL
51
4
JCI
50
-9
KO
65
10
RRC
65
-3
VZ
52
5
VFC
43
4
Financhill
Back

Franklin Street Properties Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
31

FSP
Franklin Street Properties

Last Price:
$1.86
Seasonality Move:
-4.11%
Sell
41

ALNY
Alnylam Pharmaceuticals

Last Price:
$270.24
Seasonality Move:
7.6%
Sell
31
Franklin Street Properties (FSP) is a Sell

Is Franklin Street Properties a Buy, Sell or Hold?

  • The current Franklin Street Properties [FSP] share price is $1.83. The Score for FSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • FSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $269.21. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FSP Stock Price Chart

What is Franklin Street Properties's stock price today?

  • The Franklin Street Properties share price today is $1.83
    The current trend is relatively stagnant and FSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $269.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

FSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.37 Sell
Chaikin Money Flow: 230723 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.77 - 1.93) Sell
Bollinger Bands (100): (1.79 - 1.93) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.33 Buy
Relative Strength Index (14 RSI): 56.44 Buy
Chaikin Money Flow: -958699 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.07 - 265.67) Buy
Bollinger Bands (100): (240.5 - 271.04) Buy

FSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.83 Sell
20-day SMA: 1.82 Buy
50-day SMA: 1.84 Sell
200-day SMA: 1.76 Buy
8-day EMA: 1.83 Buy
20-day EMA: 1.83 Sell
50-day EMA: 1.84 Sell
200-day EMA: 1.85 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.08 Buy
20-day SMA: 252.48 Buy
50-day SMA: 259.02 Buy
200-day SMA: 252.75 Buy
8-day EMA: 268.02 Buy
20-day EMA: 259.47 Buy
50-day EMA: 256.9 Buy
200-day EMA: 244.06 Buy

Franklin Street Properties Earnings Growth & FSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Franklin Street Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):